A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples